Company: LRHC
Filing Date: 2025-08-18
Form Type: 10-Q
Source: 0001213900-25-078012
Chunk: 131

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-18
Form: 10-Q
Item: Item 2
Chunk 131
---
Facility Agreement”) with an institutional investor (the
“Facility Investor”), pursuant to which the Facility Investor committed to purchase, subject to certain conditions and limitations,
up to $150,000,000 (the “Commitment Amount”) in newly issued shares of the common stock of the Company (the “Facility”).
In connection with the Facility, on the Agreement Date the Company also entered into a Registration Rights Agreement (the “RRA”)
with the Facility Investor.

Pursuant to the terms of the Facility Agreement,
the issuance of shares of common stock in excess of 19.99% of the Company’s outstanding shares of common stock is conditional upon
obtaining the approval of the Company’s stockholders in accordance with the rules and regulations of the Nasdaq Capital Market.
On August 6, 2025, the stockholders, holding approximately 96.3% of the votes of our outstanding voting stock approved the Facility Agreement
and RRA, including, but not limited to the issuance of the shares of common stock in excess of 19.99% of the Company’s issued and
outstanding common stock at a price less than the minimum price required by the Nasdaq Capital Market, in compliance with the rules and
regulations of the Nasdaq Capital Market. On August 8, 2025, the Company filed a preliminary information statement on Schedule 14C with
the SEC notifying stockholders of such approval. The Company filed a definitive information statement on Schedule 14C with
the SEC and commenced mailing of the definitive information statement to stockholders of record on August 18, 2025. Such stockholders’
approval will become effective 20 calendar days after commencement of mailing, or September 7, 2025.

32

February 2025 Financing and June 2025 Exchange Agreement

On February 4, 2025 (“Closing Date”),
we entered into the SPA with an institutional investor (“2025 Investor”) pursuant to which we agreed to issued and sell to
the 2025 Investor upon the terms and conditions set forth in the SPA on such date: (i) a Senior Secured Convertible Note in the original
principal amount of $5,500,000 which matures on the two-year anniversary of the Closing Date (the “Initial Note”); and (ii)
sixteen (16) warrants (the “Incremental Warrants”), each to purchase additional Notes in an original principal amount up
to $2,500,000 at an